Fresenius Medical Care AG & Co. (Pref) (FME) Given a €95.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €95.00 ($111.76) price objective on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report sent to investors on Thursday. The brokerage currently has a buy rating on the stock.

FME has been the subject of a number of other research reports. Citigroup Inc set a €92.00 ($108.24) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Tuesday, August 8th. Deutsche Bank AG set a €85.00 ($100.00) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a report on Wednesday, August 2nd. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Monday, July 24th. Commerzbank Ag set a €88.00 ($103.53) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a report on Tuesday, August 1st. Finally, Independent Research GmbH set a €88.00 ($103.53) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have issued a buy rating to the company’s stock. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of Hold and a consensus target price of €89.12 ($104.84).

Shares of Fresenius Medical Care AG & Co. (FME) traded up €0.18 ($0.21) during mid-day trading on Thursday, hitting €83.20 ($97.88). 656,887 shares of the company traded hands.

TRADEMARK VIOLATION NOTICE: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2017/11/04/fresenius-medical-care-ag-95-00-price-target-at-kepler-capital-markets.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. (Pref)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. (Pref) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit